Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and ym 09151-2

3,4-dihydroxyphenylacetic acid has been researched along with ym 09151-2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akimoto, K; Akiyama, K; Hamamura, T; Kashihara, K; Okumura, K; Otsuki, S; Ujike, H1
Kobayashi, M; Koshikawa, N; Noguchi, M; Tomiyama, K1
Albers, DS; Augood, SJ; Breakefield, XO; Hollingsworth, Z; Leung, J; Standaert, DG; Yang, L1

Other Studies

3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and ym 09151-2

ArticleYear
Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
    Brain research, 1991, Apr-12, Volume: 546, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Behavior, Animal; Benzamides; Benzazepines; Brain Chemistry; Corpus Striatum; Dialysis; Dopamine; Dopamine Antagonists; Homovanillic Acid; Male; Methamphetamine; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Synaptic Transmission

1991
YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Journal of neurochemistry, 1993, Volume: 60, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Calcium; Cerebrospinal Fluid; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Injections; Isotonic Solutions; Male; Nomifensine; Rats; Ringer's Solution; Sulpiride; Tetrodotoxin

1993
Dopamine transmission in DYT1 dystonia.
    Advances in neurology, 2004, Volume: 94

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dystonia; Family Health; Homovanillic Acid; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Chaperones; Neuropeptides; Synaptic Transmission; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins

2004